Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2008 AND VI 26 AND IP 5
Results: 10
1
2
Economic evaluation of interventions to treat opiate dependence : a review of the evidence.
- Published in:
- 2008
- By:
- Publication type:
- journal article
3
Perspectives on patient-reported outcomes : content validity and qualitative research in a changing clinical trial environment.
- Published in:
- 2008
- By:
- Publication type:
- journal article
4
Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-α Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia.
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 5, p. 435, doi. 10.2165/00019053-200826050-00007
- By:
- Publication type:
- Article
5
A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.
- Published in:
- 2008
- By:
- Publication type:
- journal article
6
Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making.
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 5, p. 409, doi. 10.2165/00019053-200826050-00005
- By:
- Publication type:
- Article
7
Economic Evaluations in Rheumatoid Arthritis: A Critical Review of Measures Used to Define Health States.
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 5, p. 395, doi. 10.2165/00019053-200826050-00004
- By:
- Publication type:
- Article
8
Economic Evaluation of Interventions to Treat Opiate Dependence: A Review of the Evidence.
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 5, p. 371, doi. 10.2165/00019053-200826050-00003
- By:
- Publication type:
- Article
9
Perspectives on Patient-Reported Outcomes: Content Validity and Qualitative Research in a Changing Clinical Trial Environment.
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 5, p. 363, doi. 10.2165/00019053-200826050-00002
- By:
- Publication type:
- Article
10
Cost-Effectiveness Analysis: Developing Nations Left Behind.
- Published in:
- 2008
- By:
- Publication type:
- Editorial